CME

CME Group Inc.

$293.53

-0.12% 2026-10-19

FinancialsS&P 500

1M 3M 6M 1Y 2Y

CMESPY

+5.9%

+6.3%

+20.3%

+3.1%

YTD

+11.1%

+13.8%

Grades vs sector

Momentum

32nd pct in sector

C-

12-1 return: +2.5%
Percentile within its GICS sector across the S&P 1500.

Growth

15th pct in sector

D-

Revenue growth (YoY): +0.8%
Percentile within its GICS sector across the S&P 1500.

Value

7th pct in sector

Forward E/P: 4.4% · EBITDA/EV: 4.4%
Percentile within its GICS sector across the S&P 1500.

Profitability

80th pct in sector

B+

Profit margin: +63.4% · Return on equity: +15.8%
Percentile within its GICS sector across the S&P 1500.

Revisions

no data

–

EPS estimate change, 30 days (current FY): –
30-day change in analysts' current-year EPS estimate; graded across covered stocks.

Our models

Not held by any of our 3 live models right now.

Momentum Top 15

rank 263 of 499 · 12-1 momentum % 9.2

Quality Growth

not ranked (outside this model's universe or screens)

Momentum Blend

not in the current book

Key stats

Market cap$105.5B

P/E (trailing)24.9

P/E (forward)22.6

52-week range218.31 – 329.16

Revenue growth (YoY, latest qtr)+0.8%

Dividend yield1.77%

Analyst consensusHold (16)

Mean price target$292.94 (-0%)

Valuation & fundamentals

Bottom line

Looks expensive

Model read-out from the numbers below, not advice. Score -3 (DCF counts double).

▼DCF (base case)below the price by 28%

▼Forward P/E vs sector22.6x vs median 10.2x

•Piotroski F-score6/9

▲Net debt / EBITDA-0.5x

•Analyst target-0% (16 analysts)

Discounted cash flow

Bear

$136

-54%

growth -0% · disc. 10.2% · term. 2.0%

Base

$211

-28%

growth 5% · disc. 9.2% · term. 2.5%

Bull

$313

+7%

growth 8% · disc. 8.2% · term. 3.0%

A DCF starts from trailing free cash flow, so it can overstate value if the last 12 months were unusually strong (or weak). Use the bear case or edit the starting cash flow if so.

Reverse DCFfor context, not a signal

Today's price assumes free cash flow grows about 9% a year for 10 years.

Implied

+9%/yr

FCF, last 3 yrs

+12%/yr

FCF, last 5 yrs

+11%/yr

Revenue, last 3 yrs

+9%/yr

Revenue, last 5 yrs

+6%/yr

Same inputs as the DCF above: trailing free cash flow 4.2B, 9.2% discount rate, 2.5% growth after year 10, net cash and today's share count. Actual growth rates are compound annual rates from SEC annual filings through FY2025; "n/a" means too little history or a negative starting year.

Edit assumptions · recalculates instantly

Your value per share–

Free cash flow = operating cash flow − capital spending, trailing 12 months (TTM to 2026-06-30). Growth default: average of 3-year revenue CAGR and latest revenue growth, capped at 30%. Years 6–10 fade linearly to terminal growth. Discount rate = 4.25% risk-free assumption + beta 0.27 × 5% equity premium, kept within 7–13%. Bear: lower growth, +1 pt discount, 2% terminal. Bull: higher growth, −1 pt, 3%.

Multiples vs Financials

P/E (trailing)

sector median 13.0× · 85th pct

24.9×
pricier

Forward P/E

sector median 10.2× · 96th pct

22.6×
pricier

EV / EBITDA

sector median 10.9× · 91st pct

22.9×
pricier

Price / sales

sector median 2.8× · 88th pct

15.6×
pricier

Price / book

sector median 1.6× · 84th pct

4.0×
pricier

FCF yield

sector median 8.2% · 17th pct

4.0%
pricier

Forward EPS $13.00 vs trailing $11.79 (+10% expected growth). Forward P/E uses analysts' next-12-month estimate.

Quality & financial health

Gross margin

–

Operating margin

65.1%

FCF margin

62.2%

Net margin

63.3%

Return on equity

16.2%

Return on invested capital

13.9%

Net debt / EBITDA

-0.5×

Current ratio

1.0×

Interest cover

–

Cash conversion (OCF/NI)

1.0×

Piotroski F-score 6/9 · last two fiscal years

✓ Positive net income✓ Positive operating cash flow✗ Return on assets improved✓ Cash flow above net income✓ Long-term debt / assets fell✓ Current ratio improved✓ No share dilution✗ Gross margin improved✗ Asset turnover improved

Analysts

Mean target

$293

-0%

Analysts

Hold

Range

$218–$337

low – high

● price · ◆ mean target

Annual history

FY	Revenue	Net income	Free cash flow
2025	$6.5B	$4.1B	$4.2B
2024	$6.1B	$3.5B	$3.6B
2023	$5.6B	$3.2B	$3.4B
2022	$5.0B	$2.7B	$3.0B
2021	$4.7B	$2.6B	$2.3B
2020	$4.9B	$2.1B	$2.5B

From the company's 10-K filings via SEC XBRL. 3-year revenue CAGR +9.1%.

Earnings

Next report: 2026-10-21 · before open · EPS est 2.98

EstimateActual (beat)Actual (miss)

Report	EPS est	Actual	Surprise
2026-07-22	2.91	2.99	+2.8%
2026-04-22	3.37	3.36	-0.2%
2026-02-04	2.74	2.77	+1.0%
2025-10-22	2.63	2.68	+2.0%
2025-07-23	2.92	2.96	+1.4%
2025-04-23	2.81	2.80	-0.3%
2025-02-12	2.45	2.52	+3.0%
2024-10-23	2.65	2.68	+1.0%

Quarterly revenue

Quarter	Revenue	YoY
2026-06-30	$1.7B	+0.8%
2026-03-31	$1.9B	–
2025-12-31	$1.6B	–
2025-09-30	$1.5B	–
2025-06-30	$1.7B	–

Analyst actions

Wells Fargo

2026-10-14 · main

Overweight → Overweight
PT $315

Morgan Stanley

2026-10-09 · main

Overweight → Overweight
PT $337

Barclays

2026-10-07 · main

Equal-Weight → Equal-Weight
PT $281

UBS

2026-10-05 · main

Neutral → Neutral
PT $270

TD Cowen

2026-10-05 · main

Buy → Buy
PT $300

Wells Fargo

2026-10-02 · init

→ Overweight
PT $301

Recent dividends

2026-09-09: $1.300 · 2026-06-09: $1.300 · 2026-03-10: $7.450 · 2025-12-12: $1.250 · 2025-09-09: $1.250 · 2025-06-09: $1.250 · 2025-03-07: $1.250 · 2024-12-27: $5.800

Insider trades

Shepard William R

Director · 2026-09-25

BUY
$78.6K

Cook Elizabeth A

Director · 2026-09-14

SELL
$140.1K

Duffy Terrence A

Director, Chairman and CEO · 2026-09-10

SELL
$3.9M

Duffy Terrence A

Director, Chairman and CEO · 2026-09-10

SELL
$172.7K

None

None · None

SELL
–

None

None · None

SELL
–

None

None · None

SELL
–

None

None · None

SELL
–

None

None · None

SELL
–

None

None · None

SELL
–

None

None · None

SELL
–

None

None · None

SELL
–

News

CME vs. Coinbase Global: Which Financial Stock Is a Better Buy in 2026?

Nasdaq · 9h ago

CME Crosses Above Average Analyst Target

Nasdaq · 13h ago

Stats refreshed 2026-10-19 19:19:44 ET from Yahoo Finance (yfinance). "–" means the data isn't available. Refresh now

coteau

Hypothetical research for education, not investment advice. Data: Yahoo Finance (via yfinance, delayed), SEC EDGAR.

Disclaimer Terms Privacy Glossary Track record Data status